In a statement, Bharat Bio said CEPI will fund the consortium for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Y20f1F
via IFTTT
0 comments:
Post a Comment